Oxford Nanopore Technologies News
Most Popular Oxford Nanopore Technologies Story
Illumina deal highlights hunt for sub-$1,000 sequencing
The Wall Street Journal analyzes the thinking behind Illumina's deal to acquire a stake in the UK's Oxford Nanopore Technologies. Oxford Nanopore has been developing new sequencing technology that... Read more...
Latest Headlines
- January 13, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
